Financial Summary for the Second Quarter (Interim) of the Fiscal Year Ending March 2027 [Japanese GAAP] (Consolidated)

Summary of Results

Consolidated results for the period recorded revenue of 1,001,960 thousand yen (YoY -3.8%), operating loss of 32,448 thousand yen, ordinary loss of 22,763 thousand yen, and net interim loss attributable to owners of the parent of 19,255 thousand yen. By segment, healthcare equipment-related sales increased, while X-ray residual stress measurement equipment saw an increase in order backlog but sluggish sales, and optical application & special equipment remained favorable. The full-year forecast is unchanged from the previously announced guidance. Cash and cash equivalents decreased, and the asset composition changed due to the acquisition of investment securities and other factors.

Outlook and Impact

Interim results continue to face a challenging environment, with order conditions affected by prolonged component lead times. In the short term, stabilizing parts supply and flexible proposals to meet customer requirements will be important. The full-year outlook remains unchanged, but performance could be affected depending on segment-level recovery. Capital allocation priorities include improving cash flow and optimizing investments.